
About
Dr. Masato Iwasaki, Ph.D., is Independent Outside Director of Olympus Corporation from June 2024. Dr. Iwasaki serves as Advisor at Gazelle Capital, Inc. since August 18, 2023. He is Advisor at Catalys Pacific. He had been a Representative Director at Takeda Pharmaceutical Company Limited since June 29, 2021 until June 28, 2023. He served as an Independent Outside Director of JSR Corporation since June 17, 2022 until June 27, 2024. He was President of Japan Pharma Business Unit at Takeda Pharmaceutical Company Limited since 2015 until March 31, 2021. Dr. Iwasaki served as Senior Vice President of Pharmaceutical Marketing Division at Takeda Pharmaceutical Company Limited since April 1, 2012. He served as Head of CSMO Office at Takeda Pharmaceuticals International Inc since January 2012. He joined Takeda Pharmaceutical Company Limited in 1985 and had an extensive career in roles of increasing responsibility in sales and marketing under the Pharmaceutical Marketing Division. He served as Vice President of Human Resources Management Department – Pharmaceutical Marketing Division at Takeda Pharmaceutical Company Ltd. He served as Senior Vice President of Strategic Product Planning Department at Takeda Pharmaceutical Company Limited since 2008 and served as its Corporate Officer since 2010. In 2003, Dr. Iwasaki was appointed Manager of Strategic Product Planning and Project Leader for the Cardiovascular and Metabolic franchise. Dr. Iwasaki had been a Director at Takeda Pharmaceutical Company Limited since June 26, 2012 until June 29, 2021
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Olympus Corporation | Board | Member | 01/06/2024 | |
| Olympus Corporation | Nominations & Governance | Member | 01/06/2024 |